147 results
Page 3 of 8
8-K
EX-10.1
vn44 gv3xcjwflo
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm
424B3
qmqi9oyt l93lmma
28 Jun 23
Prospectus supplement
4:56pm
424B3
a27wffjh
4 May 23
Prospectus supplement
4:30pm
8-K
EX-99.1
547p5t1sy knimbd87
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
8-K
EX-4.3
w9c 4cq8qavh
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-4.2
anle25x8ft2ki
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-1.1
zruvr
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am